[1] LIANG X, BI S, YANG W, et al. Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination[J]. Vaccine, 2009, 27 (47) :6550-6557.
|
[2] WANG HJ, DUAN ZP, ZHANG HH, et al. Research advances in the application of antiviral drugs during pregnancy for blocking mother-to-child transmission of hepatitis B virus[J]. J Clin Hepatol, 2018, 34 (10) :2208-2212. (in Chinese) 王慧娟, 段钟平, 张桓虎, 等.孕期服用抗病毒药物阻断HBV母婴传播的研究进展[J].临床肝胆病杂志, 2018, 34 (10) :2208-2212.
|
[3] HAN GR, CAO MK, ZHAO W, et al. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection[J]. J Hepatol, 2011, 55 (6) :1215-1221.
|
[4] SUN KX, LI J, ZHU FC, et al. A predictive value of quantitative HBsAg for serum HBV DNA level among HBe Ag-positive pregnant women[J]. Vaccine, 2012, 30 (36) :5335-5340.
|
[5] CHEN T, WANG J, FENG Y, et al. Dynamic changes of HBV markers and HBV DNA load in infants born to HBsAg (+) mothers:Can positivity of HBsAg or HBV DNA at birth be an indicator for HBV infection of infants?[J]. BMC Infect Dis, 2013, 13 (1) :524.
|
[6] LIU J, ZHANG S, WANG Q, et al. Seroepidemiology of hepatitis B virus infection in 2 million men aged 21-49 years in rural China:A population-based, cross-sectional study[J].Lancet Infect Dis, 2016, 16 (1) :80-86.
|
[7] DING Y, SHENG Q, MA L, et al. Chronic HBV infection among pregnant women and their infants in Shenyang, China[J]. Virol J, 2013, 10:17.
|
[8] HUANG Y, LI L, SUN X, et al. Screening of pregnant women for hepatitis B virus surface antigen (HBs Ag) and subsequent management, Qiandongnan prefecture, Guizhou, China, 2010[J].Vaccine, 2013, 31 (Suppl 9) :j62-j65.
|
[9] LIU JN. Awareness on the prevention and treatment of hepatitis B virus infection and mother-to-child transmission among the pregnant women of the first antenatal examination[J/CD].Chin J Exp Clin Infect Dis:Electronic Edition, 2019, 13 (1) :65-69. (in Chinese) 刘佳妮.初次产检孕妇对乙型肝炎病毒感染及母婴传播防治措施知晓度分析[J/CD].中华实验和临床感染病杂志:电子版, 2019, 13 (1) :65-69.
|
[10] WEN WH, CHANG MH, ZHAO LL, et al. Mother-to-infant transmission of hepatitis B virus infection:Significance of maternal viral load and strategies for intervention[J]. J Hepatol, 2013, 59 (1) :24-30.
|
[11] SONG YM, SUNG J, YANG S, et al. Factors associated with immunoprophylaxis failure against vertical transmission of hepatitis B virus[J]. Eur J Pediatr, 2007, 166 (8) :813-818.
|
[12] GUO Z, SHI XH, FENG YL, et al. Risk factors of HBV intrauterine transmission among HBsAg-positive pregnant women[J]. J Viral Hepat, 2013, 20 (5) :317-321.
|
[13] LI XM, SHI MF, YANG YB, et al. Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection[J]. World J Gastroenterol, 2004, 10 (21) :3215-3217.
|
[14] OGUNBUSI O, SMUTS H, ELEY B, et al. Fulminant hepatitis B virus (HBV) infection in an infant following mother-tochild transmission of an e-minus HBV mutant:Time to relook at HBV prophylaxis in South African infants[J]. S Afr Med J, 2018, 108 (5) :389-392.
|